The headline numbers for CME (CME) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) came out with quarterly earnings of $2.52 per share, beating the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.37 per share a year ago.
CME Group (CME -0.03%), a leading derivatives marketplace known for options and futures trading, reported fourth-quarter 2024 earnings results on Wednesday, Feb. 12, that topped analysts' consensus expectations. Adjusted earnings per share (EPS) of $2.52 beat the estimate of $2.45.
CME's fourth-quarter results are likely to reflect a diverse product portfolio, increased volatility and a strong market position.
Evaluate the expected performance of CME (CME) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
I believe we are entering the perfect stock-picking market as valuations shift. With economic growth widening, opportunities beyond big tech are emerging. One of my highest-conviction picks is a unique landowner. Its high-margin business model benefits from oil, water, and data center deals. The other pick is a high-margin financial giant. With strong cash flow, minimal capital needs, and dividend potential, I see massive upside ahead.
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Rising interest rates and a significant portion of U.S. debt maturing soon pose a major risk to the economy and stock market. Elevated bond yields provide an attractive alternative to equities, making the market vulnerable to further increases in longer-term bond rates. Inflation remains a critical risk, potentially leading to higher fed funds rates and bond yields, which could negatively impact stock prices.
A strong global presence, a compelling product portfolio, focus on over-the-counter clearing services and a solid capital position poise CME well for growth.